Filing Details
Evolus, Inc. (NASDAQ:EOLS) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNASDAQ:EOLS
Evolus, Inc. (EOLS) Reports Material Event to SEC
Filing Details Evolus, Inc. (NASDAQ:EOLS) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market Context Evolus,…
Market Context
Evolus, Inc.'s stock currently trades at $6.12 with a market capitalization of $448.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Evolus, Inc.'s stock.
All SEC filings for Evolus, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View EOLS Stock Page
Frequently Asked Questions
Where can I read EOLS's SEC filings?
Browse all filings on our EOLS SEC filings page.
What types of SEC filings does Evolus, Inc. file?
Public companies like Evolus, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.